Soren P. Jorgensen
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Quality of Life in Patients With Primary Sclerosing Cholangitis.
Journal: Gastro hep advances
Published: November 07, 2025
Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.
Journal: Nutrients
Published: November 05, 2020
Letter: post-infective bile acid malabsorption and diarrhoea. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 12, 2019
Letter: long-term treatment of severe bile acid diarrhoea-obeticholic acid can normalise SeHCAT retention. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: October 16, 2018
Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature.
Journal: World journal of gastroenterology
Published: January 20, 2018
Long-term effect of medical treatment of diarrhoea in 377 patients with SeHCAT scan diagnosed bile acid malabsorption from 2003 to 2016; a retrospective study.
Journal: Alimentary pharmacology & therapeutics
Published: September 13, 2017
Vitamin D increases programmed death receptor-1 expression in Crohn's disease.
Journal: Oncotarget
Published: November 18, 2016
Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding.
Journal: Danish medical journal
Published: April 16, 2015
Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease.
Journal: Clinical and experimental immunology
Published: October 28, 2014
Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients.
Journal: Inflammopharmacology
Published: August 05, 2013
Last Updated: 09/26/2026